FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312962757> ?p ?o ?g. }

• W4312962757 endingPage "297" @default.
• W4312962757 startingPage "297" @default.
• W4312962757 abstract "To assess the efficacy and safety of a single preoperative intralesional bevacizumab injection as an adjuvant treatment before primary pterygium surgery.We conducted a randomized controlled interventional study from January 2019 to December 2020. The study included a total of 60 patients (60 eyes) with primary pterygium. We defined two groups of 30 patients each. Group A received an intralesional injection of bevacizumab (Avastin), 1 month before surgery (lesion excision and conjunctival autograft). Group B (control) had only the surgical treatment. Patients were followed up 7 days (D7), 1 month (M1), 3 months (M3), and 6 months (M6) postoperatively. Pre-, per-, and postoperatively, photographs of the lesions were taken, as well as a histopathological examination. The main outcome measures were the change in functional discomfort following intralesional bevacizumab injection and pterygium recurrence. Recurrence was defined as fibrovascular tissue growth invading the cornea. Therapeutic success was defined as the absence of pterygium recurrence in M6.The mean age of the 60 patients was 54.17 ± 10.53. After bevacizumab injection, the preoperative functional discomfort score decreased significantly (P = 0.048). There was a significant improvement in grade and color intensity (P = 0.001). We noted no local nor systemic complications after intralesional injection of bevacizumab. After pterygium excision, the success rate was statistically higher in Group A (P = 0.047). There was no significant difference in either final best-corrected spectral visual acuity or astigmatism between the two groups. We noted a statistically significant association between recurrence and color intensity (P = 0.046), vascular density (P = 0.049), and the degree of elastic tissue degeneration (P = 0.040).A single preoperative subconjunctival injection of bevacizumab 1 month before surgery decreases the vascularity of newly formed blood vessels and hence may reduce the recurrence rate." @default.
• W4312962757 created "2023-01-05" @default.
• W4312962757 creator A5026394890 @default.
• W4312962757 creator A5028578639 @default.
• W4312962757 creator A5065825077 @default.
• W4312962757 creator A5068107154 @default.
• W4312962757 creator A5072516514 @default.
• W4312962757 creator A5074290478 @default.
• W4312962757 creator A5076153783 @default.
• W4312962757 creator A5087524868 @default.
• W4312962757 creator A5087531922 @default.
• W4312962757 creator A5091013662 @default.
• W4312962757 creator A5091594839 @default.
• W4312962757 date "2022-01-01" @default.
• W4312962757 modified "2023-10-18" @default.
• W4312962757 title "Preoperative Intralesional Bevacizumab Injection in Primary Pterygium in Tunisian Patients: A Randomized Controlled Prospective Study" @default.
• W4312962757 cites W118311587 @default.
• W4312962757 cites W1537746104 @default.
• W4312962757 cites W1971613885 @default.
• W4312962757 cites W1980530298 @default.
• W4312962757 cites W1981983303 @default.
• W4312962757 cites W1987759761 @default.
• W4312962757 cites W1999368079 @default.
• W4312962757 cites W2000301280 @default.
• W4312962757 cites W2003084774 @default.
• W4312962757 cites W2017005743 @default.
• W4312962757 cites W2027267451 @default.
• W4312962757 cites W2032128136 @default.
• W4312962757 cites W2054870642 @default.
• W4312962757 cites W2058264327 @default.
• W4312962757 cites W2073868523 @default.
• W4312962757 cites W2083131865 @default.
• W4312962757 cites W2095091295 @default.
• W4312962757 cites W2115076925 @default.
• W4312962757 cites W2166359305 @default.
• W4312962757 cites W2262102571 @default.
• W4312962757 cites W2278995704 @default.
• W4312962757 cites W2336485346 @default.
• W4312962757 cites W2404204832 @default.
• W4312962757 cites W2559483541 @default.
• W4312962757 cites W2620229598 @default.
• W4312962757 cites W2790600564 @default.
• W4312962757 cites W2900143943 @default.
• W4312962757 cites W3005415926 @default.
• W4312962757 cites W3018006566 @default.
• W4312962757 cites W3178297811 @default.
• W4312962757 cites W3205704999 @default.
• W4312962757 cites W55661547 @default.
• W4312962757 doi "https://doi.org/10.4103/joco.joco_146_22" @default.
• W4312962757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36644467" @default.
• W4312962757 hasPublicationYear "2022" @default.
• W4312962757 type Work @default.
• W4312962757 citedByCount "0" @default.
• W4312962757 crossrefType "journal-article" @default.
• W4312962757 hasAuthorship W4312962757A5026394890 @default.
• W4312962757 hasAuthorship W4312962757A5028578639 @default.
• W4312962757 hasAuthorship W4312962757A5065825077 @default.
• W4312962757 hasAuthorship W4312962757A5068107154 @default.
• W4312962757 hasAuthorship W4312962757A5072516514 @default.
• W4312962757 hasAuthorship W4312962757A5074290478 @default.
• W4312962757 hasAuthorship W4312962757A5076153783 @default.
• W4312962757 hasAuthorship W4312962757A5087524868 @default.
• W4312962757 hasAuthorship W4312962757A5087531922 @default.
• W4312962757 hasAuthorship W4312962757A5091013662 @default.
• W4312962757 hasAuthorship W4312962757A5091594839 @default.
• W4312962757 hasBestOaLocation W43129627571 @default.
• W4312962757 hasConcept C109821595 @default.
• W4312962757 hasConcept C118487528 @default.
• W4312962757 hasConcept C120665830 @default.
• W4312962757 hasConcept C121332964 @default.
• W4312962757 hasConcept C141071460 @default.
• W4312962757 hasConcept C168563851 @default.
• W4312962757 hasConcept C188816634 @default.
• W4312962757 hasConcept C2776694085 @default.
• W4312962757 hasConcept C2776882836 @default.
• W4312962757 hasConcept C2777802072 @default.
• W4312962757 hasConcept C2778257484 @default.
• W4312962757 hasConcept C2778266423 @default.
• W4312962757 hasConcept C2781156865 @default.
• W4312962757 hasConcept C71924100 @default.
• W4312962757 hasConceptScore W4312962757C109821595 @default.
• W4312962757 hasConceptScore W4312962757C118487528 @default.
• W4312962757 hasConceptScore W4312962757C120665830 @default.
• W4312962757 hasConceptScore W4312962757C121332964 @default.
• W4312962757 hasConceptScore W4312962757C141071460 @default.
• W4312962757 hasConceptScore W4312962757C168563851 @default.
• W4312962757 hasConceptScore W4312962757C188816634 @default.
• W4312962757 hasConceptScore W4312962757C2776694085 @default.
• W4312962757 hasConceptScore W4312962757C2776882836 @default.
• W4312962757 hasConceptScore W4312962757C2777802072 @default.
• W4312962757 hasConceptScore W4312962757C2778257484 @default.
• W4312962757 hasConceptScore W4312962757C2778266423 @default.
• W4312962757 hasConceptScore W4312962757C2781156865 @default.
• W4312962757 hasConceptScore W4312962757C71924100 @default.
• W4312962757 hasIssue "3" @default.
• W4312962757 hasLocation W43129627571 @default.
• W4312962757 hasLocation W43129627572 @default.
• W4312962757 hasLocation W43129627573 @default.

• next